GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (FRA:8JD) » Definitions » Research & Development

Valbiotis (FRA:8JD) Research & Development : €5.33 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valbiotis Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Valbiotis's Research & Development for the six months ended in Jun. 2024 was €3.19 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was €5.33 Mil.

Valbiotis Research & Development Historical Data

The historical data trend for Valbiotis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Research & Development Chart

Valbiotis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 3.97 5.41 7.03 9.10 7.15

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.06 5.05 5.01 2.14 3.19

Valbiotis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €5.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valbiotis  (FRA:8JD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Valbiotis Research & Development Related Terms

Thank you for viewing the detailed overview of Valbiotis's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (FRA:8JD) » Definitions » Research & Development
Comparable Companies
XPAR:MAAT XPAR:ALCLS XPAR:ALACT XPAR:OSE XPAR:ADOC XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ALVAL:France 8JD:Germany
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Website
http://www.valbiotis.com
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis Headlines

No Headlines